Additional file 1 of Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-up ...

• Main Authors: Clark, Paul J., Valery, Patricia C., Ward, James, Strasser, Simone I., Weltman, Martin, Thompson, Alexander, Levy, Miriam T., Leggett, Barbara, Zekry, Amany, Rong, Julian, Angus, Peter, George, Jacob, Bollipo, Steven, McGarity, Bruce, Sievert, William, Macquillan, Gerry, Tse, Edmund, Nicoll, Amanda, Wade, Amanda, Chu, Geoff, Harding, Damian, Cheng, Wendy, Farrell, Geoff, Roberts, Stuart K.
• Format: Text
• Language: unknown
• Published: figshare 2022
• Subjects: Medicine; Science Policy; Mental Health; Infectious Diseases; FOS Health sciences; First Nations
• Online Access: https://dx.doi.org/10.6084/m9.figshare.20296534; https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Hepatitis_C_treatment_outcomes_for_Australian_First_Nations_Peoples_equivalent_SVR_rate_but_higher_rates_of_loss_to_follow-up/20296534

Additional file 1. Supplementary Table S1. List of Rx-Risk-V comorbidity categories with corresponding medicine groups and Anatomical Therapeutic Chemical (ATC), and ATC codes of medications dispensed to patients included in the Opera-C study. Supplementary Table 2. Prevalence of comorbidity categories included in the Rx-Risk-V according for First Nations Peoples and non-Indigenous Australians. Supplementary Table 3. Logistic regression analysis of factors associated with loss to follow-up among First Nations Peoples. ...